Symbiotec Pharmalab Ltd vs Divi's Lab.
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Symbiotec Pharmalab Ltd currently has the stronger revenue growth signal.
Symbiotec Pharmalab Ltd and Divi's Lab. show active capex signals based on earnings call analysis.
Symbiotec Pharmalab Ltd show fundraising activity or capital structure signals.
| Metric | Symbiotec Pharmalab Ltd | Divi's Lab. |
|---|---|---|
| Current Price | ₹1,056 | ₹9,431 |
| Market Cap | ₹6,447.14 Cr. | ₹2.55 L Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | 64.82 | 85.71 |
| ROE (%) | 11.74 | 16.53 |
| Debt/Equity | 0.34 | — |
| Sales Growth 5Y (%) | 6.55 | 8.67 |
| Profit Growth 5Y (%) | — | 61.75 |
| Promoter Holding (%) | 33.28 | 51.88 |
| Revenue Rank | Rank 2 | Rank 3 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | Yes | No information |